Elaine Chen and Allison DeAngelis

BioTech

NIH funding cuts, a U.S. brain drain, and bold claims from AI drug developers

What are “indirect costs” for universities? Why are some young scientists looking at opportunities abroad? And why are AI drug developers so secretive? We bring

Elaine Chen and Allison DeAngelis February 13, 2025

BioTech

Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target

Nearly two decades ago, a small company called Amylin Pharmaceuticals saw that its first commercial product, a diabetes treatment targeting receptors of the amylin hormone,

Elaine Chen and Allison DeAngelis September 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Elaine Chen and Allison DeAngelis

NIH funding cuts, a U.S. brain drain, and bold claims from AI drug developers

Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe